Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation

Conditions:   Liver Transplant; Complications;   Hepatocarcinoma;   Recurrent Osteosarcoma;   High-Risk Cancer Intervention:   Drug: multi-kinase inhibitors in combination with bevacizumab Sponsor:   Peking Union Medical College Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials